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Percutaneous Placement of Self-expandable
Metallic Biliary Stents in Malignant
Extrahepatic Strictures: Indications of
Transpapillary and Suprapapillary Methods
Objective: To compare the efficacy of suprapapillary and transpapillary meth-
ods of transhepatic biliary metallic stent placement in malignant biliary strictures
and to specify the indications of each method applied. 
Materials and Methods: Stents were placed in 59 patients. Strictures were cat-
egorized as type A (within 3 cm of the ampulla, n = 27), type B (over 3 cm from
ampulla, n = 7), type C (within 3 cm of the bending portion, n = 9), or type D (over
3 cm above the bending portion, n=16). The stenting method was suprapapillary
in 34 cases and transpapillary in 25. The rates of initial and long-term patency
and of early recurrence were compared. 
Results: Initial patency rates for the suprapapillary and transpapillary methods
were 1/7 (14.3%) and 20/20 (100%) respectively for type A (p < 0.0001), 4/5
(80.0%) and 2/2 for type B, 3/7 (42.9%) and 2/2 for type C, and 15/16 (93.8%)
and 0/0 for type D. Early recurrence rates were 7/30 (23.3%) using the suprapap-
illary method and 4/29 (13.8%) using the transpapillary method (p = 0.51). The
long-term patency rate did not differ significantly according to either type (p =
0.37) or method (p = 0.62).
Conclusion: For good initial patency, the transpapillary method is recommend-
ed for strictures of the distal extrahepatic duct near the ampulla and just above
the bending portion. Long-term patency is not influenced by the stenting method
employed. 
etallic stents have been successfully applied for the palliation of malig-
nant biliary strictures due to various causes (1 7), and from a technical
viewpoint, the placement technique in extrahepatic strictures is relatively
straightforward. There is a consensus among interventional radiologists that to prevent
tumor overgrowth, a safety margin of at least 2 cm should be left at each end of the
upper and lower margins of the stricture (over-stenting) (4 6, 8). A high proportion of
patients with extrahepatic duct (EHD) strictures can be palliated without crossing the
ampulla of Vater (suprapapillary method). 
Not infrequently, however, this basic rule regarding the level of strictures and
anatomic characteristics of the EHD must be modified, and the stent crossing is thus
placed at the ampulla of Vater (transpapillary method) (2). In addition, we have often
been faced with a cholangiogram showing various degrees of angulation formed by the
distal and proximal portion of the EHD, especially at its distal one third portion, and
this can be exaggerated after stent placement (Fig. 1) (9, 10). When the suprapapillary
method is used for stent placement, this kind of anatomic feature may play a negative
role in stent patency (10). 
In spite of concerns over the disadvantages of the transpapillary method, only a few
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Mcase reports have lent weight to such assertations (11 15).
The purpose of this study is to compare the efficacy of the
suprapapillary and transpapillary methods of percutaneous
transhepatic biliary metallic stent placement in the pallia-
tion of malignant EHD strictures and to specify the indica-
tions of each method. We focused on the cholangiographic
features of EHD strictures: location of the stricture within
the bile duct and the relationship between the strictures
and angulation of the EHD.
MATERIALS AND METHODS
Patients
We retrospectively reviewed the cholangiographic find-
ings and hospital records of 67 patients who between
January 1997 and May 1999 had undergone metallic bil-
iary stent placement for the palliation of malignant extra-
hepatic strictures including Klatskin tumors and peripheral
cholangiocarcinoma invading the confluence of the intra-
hepatic ducts. Patients with recurrence of biliary obstruc-
tion after bilioenteric anastomosis (n = 4) or inadequate
follow-up for the evaluation of stent patency (n = 4) were
excluded, and a total of 59 patients were thus enrolled in
this study. Thirty-six were male and 23 were female, and
their mean age was 63.6 (range, 25 82) years. The causes
of extrahepatic strictures were as follows: common duct
cancer (n = 5), Klatskin tumor (n = 5), peripheral cholan-
giocarcinoma invading the hepatic confluence (n = 5), gall
bladder cancer (n = 5), cancer of the pancreas (n = 16), and
metastasis (n = 13) (12 gastric cancer and one adenocarci-
noma of unknown origin). Malignancy was confirmed by
surgery in 18 cases, by percutaneous needle biopsy in 19,
by bile cytology with and without brushing in eight, and on
the basis of the imaging findings of cholangiography and
CT in 14. In all 59 patients, surgical resection was deemed
impossible.
Lesion characteristics
When reviewing the cholangiograms obtained during
percutaneous transhepatic biliary drainage (PTBD) and be-
fore stent placement, we focused on the angulation formed
by the distal and proximal portion of the EHD (Fig. 1) and
the location of strictures within it (Fig. 2). All cases except
one showed a varying degree of angulation (80 170 ) be-
tween the proximal and distal portions of the EHD; in the
exceptional case, the course of the EHD from the biliary
confluence to the ampulla of Vater was straight. The area
of angulation within the EHD was termed ‘bending por-
tion’. 
To facilitate analysis, the classical method of describing
EHD strictures (16) was abandoned. According to the loca-
tion of the distal margin of the stricture relative to the am-
pulla of Vater and the bending portion of the EHD, lesions
were categorized as one of four types. Type A represented
a lesion whose distal margin was located within 3 cm of the
ampulla of Vater, regardless of the bending portion (Fig.
2A); a type-B lesion was one whose distal margin was lo-
cated more than 3 cm above the ampulla of Vater and at or
below the bending portion (Fig. 2B); type C represented a
lesion whose distal margin was located not more than 3 cm
above the bending portion (Fig. 2C), while  a lesion whose
distal margin was located over 3 cm from the bending por-
tion was categorized as Type D (Fig. 2D). 
The number of type A, B, C and D cases was 27, 7, 9,
and 16, respectively (Table 1). A case in which a straight
extrahepatic duct without angulation was noted was cate-
gorized as type A because the stricture was located within
3 cm of the ampulla. 
Procedure
Fifty-seven patients had undergone PTBD before stent
placement, and the remaining two underwent placement as
a single step. The mean time lag between PTBD and stent
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Fig. 1. Anatomically, the extrahepatic duct is not straight for its
entire course. Varying degrees of angulation between the proxi-
mal and distal axes of the extrahepatic duct can be noted.placement was 9.5 (range, 0 25) days. Informed consent
was obtained from all patients. 
Using self-expandable stainless stents (Hanaro stent; MI
Tech, Seoul, Korea) in 48 patients and Nitinol stents
(StenTech, Seoul, Korea) in 11, placement was effected
with and without balloon dilatation of the stricture. The
stainless stent was made of 0.25-mm stainless steel wire
bent in a zigzag pattern, with alternating different leg
lengths forming a spiral cylindric configuration, and for the
Nitinol stent, 0.18 or 0.20-mm nitinol wire bent in a mesh
was used
The diameter of the stent was 8 or 10 mm. The length of
stent was determined by the length of the stricture. In order
to leave sufficient safety margin at each end of the stent
within the bile duct, we generally selected a stent at least 4
cm longer than the stricture. If a stent was placed across the
ampulla of Vater (transpapillary placement), a longer one,
which would cover the distal duct, was chosen.  Mean stent
length was 6.2 (range, 3 8) cm for the suprapapillary
method, and 7.3 (range, 5 9) cm for the transpapillary.
The routes of stent insertion were right transhepatic in 25
patients, left transhepatic in 24, and bilateral trans-hepatic
in ten.
To simplify analysis, methods were classified only from
the viewpoint of location of the distal end of the stent:
whether or not it crossed the ampulla of Vater. The term
‘suprapapillary method’ was used to denote a stent place-
ment technique which did not cross the ampulla of Vater
regardless of the location of the distal end of the stent
within the EHD. The term ‘transpapillary method’ denoted
a placement technique that crossed the ampulla, the distal
end of the stent thus being located in the duodenal lumen.
In this way the function of the ampulla of Vater was sacri-
ficed. The stent was placed using the suprapapillary
method in 35 cases and the transpapillary method in 24
(Table 1). 
To permit bile drainage until the following morning, an
8.5-Fr drainage catheter (Simp-Loc; Cook, Bloomington,
Ind.) was positioned after stent placement, and the tube
was then clamped for one day. When no problem was evi-
dent after clamping the drainage tube and the cholan-
giogram indicated good passage of contrast media into the
duodenum, the drainage tube was removed. When the re-
maining waist of the stent hindered the passage of contrast
media, as occurred in a limited number of cases, a balloon
Catheter (Olbert; Boston Scientific, Watertown, Mass,
U.S.A.) with a diameter of 8 or 10 mm was used to relieve
the waist. If it was found that a previously inserted stent
inadequately decompressed the biliary system, a further
stent was placed.
Many type-A lesions were managed using the transpapil-
lary method, whereas for all type-D lesions, the suprapap-
illary method was used (Table 1). In the 35 cases in which
the superapapillary method was employed initially, anoth-
er stent was used by way of secondary intervention in five
lesions because the initial stent failed to maintain patency.
Finally they were classified into the suprapapillary method.
There were four such type-A lesions and one type C. Their
numbers are shown in parentheses in the table. 
Analysis
Percutaneous cholangiography was used to assess initial
stent patency immediately after placement. If passage of
contrast media through the stent was poor, the procedure
was regarded as inadequate. Using the Fisher exact test, ini-
tial patency rates for both the suprapapillary and transpap-
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Fig. 2. Cholangiographic categorization of
extrahepatic duct strictures according to
location of distal margin of stricture within
the bile duct and relationship with the an-
gulation of the extrahepatic duct. (A) a
stricture located within 3 cm of the ampul-
la (type A); (B) a stricture located more
than 3 cm above the ampulla and at or
below the bending portion (Type B); (C) a
stricture located above the bending por-
tion but within 3 cm of the bending portion
(type C); (D) a stricture located over 3 cm
from the bending portion (type D)
Table 1. Placement Technique Used for Each Type 
Type A B C D Total
Transpapillary Method 20(24) 2(2) 2(3) 0(0) 24(29)
Suprapapillary Method 7(3) 5(5) 7(6) 16(16) 35(30)
Total 27 7 9 16 59
The number in parentheses denotes the number of cases af-
ter secondary intervention.
AB C Dillary method were compared for each of the four types.
The causes of inadequate procedures were analyzed using
the cholangiograms obtained before, during, and after stent
placement.
Regardless of the cause of reobstruction, recurrence of
symptoms within two months of initial stent placement was
defined as ‘early recurrence’. Using Fisher’s exact test, ear-
ly recurrence rates were also compared for each of the four
types.
Long-term patency rates were also calculated. The dura-
tion of stent patency was defined as the interval between
initial placement and recurrence of symptoms because of
obstruction. Patient survival and duration of stent patency
were calculated with regard to type of lesion and the me-
thod of stent placement. Using the Kaplan-Meier method,
differences in long-term patency were compared.
RESULTS
Initial patency
All 24 cases involving the transpapillary method and 23
of 35 (65.7%) in which the suprapapillary method was
used showed good initial patency. The difference in initial
patency rate between the two methods was statistically sig-
nificant (p < .001). 
In type A, only one (14.3%) involving the seven cases of
the suprapapillary method showed good patency, whereas
all 20 in which the transpapillary method was employed
showed good passage through the stent (Fig. 3). The differ-
ence was statistically significant (p <.0001). The causes of
failure of initial patency were unpredicted stricture of the
distal extrahepatic duct near the ampulla of Vater in three
cases (Fig. 4), aggravation of distal angulation after stenting
in two, and misplacement of the stent resulting in inade-
quate coverage of the stricture at the distal portion of the
stent in one. 
With regard to type-B strictures, four of the five cases in-
volving the suprapapillary method (80.0%) showed good
patency (Fig. 5); the cause of failure of initial patency in
one case was aggravation of angulation after stent place-
ment. In two cases the transpapillary method was used,
and both were also patent. 
For type C, three of the seven cases employing the
suprapapillary method showed good patency. In the other
four, the cause of failure of initial patency was aggravation
of the preexisting angulation of the duct due to longitudi-
nal rigidity of the distal portion of the stent (Fig. 6). Two
cases involved the transpapillary method, and both were
also patent. 
For type D, stricture management relied in all cases on
the suprapapillary method, and 15 of 16 (93.8%) showed
good patency. The cause of failure of initial patency in one
case was aggravation of angulation, which can be prevent-
ed if the stent length chosen is appropriate. Because of the
small sample size, statistical significance for types B, C, and
D could not be calculated. 
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A B
Fig. 3. A 65-year-old man with pancreat-
ic head cancer. 
A. Because it was located within 3 cm of
the ampulla of Vater, the stricture was
categorized as type A. 
B. Using the transpapillary method of
stent placement, the stricture was suc-
cessfully palliated. Secondary intervention
Of the six type-A cases which showed poor patency after
initial stent placement, four underwent additional place-
ment across the ampulla of Vater, and in two balloon di-
latation of the unpredicted stricture of the distal EHD near
the ampulla of Vater was performed (Fig. 4B). In one type-
B case of poor patency due to aggravation of angulation at
the distal portion of the stent, further intervention was not
attempted. Among the four type-C cases with poor paten-
cy, one underwent transpapillary placement of an addition-
al stent immediately after initial placement, but in the oth-
er three there was no further intervention. In one type-D
case of poor patency, no further intervention took place.
After reintervention there were changes in the numbers of
cases in which the suprapapillary/transpapillary method was
employed. The new totals are shown in parentheses (see
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A B
Fig. 4. A 52-year-old man with pancreat-
ic head cancer. 
A. Because it was located within 3 cm of
the ampulla of Vater, the stricture was
categorized as type A. The passage of
contrast medium injected via a catheter
below the main stricture was good, and
we therefore initially neglected a focal
narrowing (open arrow) near the ampul-
la of Vater. 
B. The passage of contrast medium was
poor after the suprapapillary method of
stent placement was applied. The stric-
ture was dilated using an angioplasty
balloon catheter.
A B
Fig. 5. A 62-year-old man presented
with obstructed jaundice due to metasta-
tic lymphadenopathy arising from ad-
vanced gastric cancer. 
A. Because it was located over 3 cm
from the ampulla of Vater at the level of
the bending portion of the extrahepatic
duct, the stricture was categorized as
type B.
B. By means of the suprapapillary
placement method, the stricture was
successfully palliated.Table 1).
Early recurrence
Among the 30 cases in which the suprapapillary method
was used, there were seven in which early recurrence oc-
curred, including five of poor patency at initial stent place-
ment but without additional placement. There were just
two cases of early recurrence in the remaining patients, all
of whom showed good patency of the biliary tree after
stent placement. In four of 29 cases involving the transpap-
illary method (13.8%), early recurrence was noted, though
the difference was statistically insignificant (p = .51). 
Long-term patency
The overall median patency interval was 317 days. The
six-month and one-year patency rates were 58.9% and
39.4%, respectively, while the median patency intervals
for type A, B, and C were 201, 317, and 50 days, respec-
tively. We were unable to calculate the median patency in-
terval for type D. All differences were statistically insignifi-
cant (p = .39). The median patency intervals for cases in
which the suprapapillary and transpapillary methods were
used were 317 and 253 days, respectively, with no signifi-
cant statistical difference (p = .57).
DISCUSSION
For the effective palliation of malignant EHD strictures,
it is essential to consider the anatomic characteristics of the
EHD. These include the length of the bile duct and the lo-
cation of cystic duct insertion, as well as the size and
anatomic level of the obstructing tumor itself within the
EHD (4, 8). For the prevention of tumor overgrowth it is
very important to cover the bile duct for as great a dist-
tance as possible (over-stenting), leaving safety margins be-
low and above the tumorous stricture (3, 8). When stenting
the strictures located adjacent to the ampulla of Vater,
however, it is sometimes impossible to leave adequate dis-
tal safety margins. In our series, when the stent was placed
by means of the suprapapillary method in such lesions
(type A), we were often faced with poor patency just after
stent placement; this was due to unexpected narrowing dis-
tal to the stent or angulation of the bile duct below the
stent. Though we cannot adequately explain the presence
of an unexpected stricture, it may have been caused by
edematous change or spasm of the ampulla of Vater associ-
ated with the procedure, by extrinsic compression of
metastatic lymphadenopathy, or by infiltration of the tu-
mor. We believe that in such cases the transpapillary
method should be used.
In addition, we emphasize the importance of natural
bending (angulation) of the EHD for successful palliation of
the obstruction. The course of the extrahepatic duct from
the confluence of the hepatic duct to the ampulla of Vater
is, in most cases, not straight. Anatomically, the supraduo-
denal and retroduodenal segments of the extrahepatic duct
slant obliquely from the right to the left, and below them
the pancreatic segment curves rather sharply to the right to
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A B
Fig. 6. A 56-year-old man with common
hepatic duct cancer. 
A. Because it was located not more than
3 cm above the bending portion of the
extrahepatic duct, the stricture was cate-
gorized as type C. Note the bending
portion below the stricture (arrow). 
B. The stricture was palliated by means
of the suprapapillary placement method.
A cholangiogram obtained the following
day demonstrated, however, that the an-
gulation below the stricture was aggra-
vated by the stretching effect of the
stent. Note the presence of a significant-
ly dilated intrahepatic duct, indicating
poor passage of contrast medium
through the extrahepatic duct.enter the descending duodenum via its posteromedial sur-
face (18). The overall course of the extrahepatic duct re-
sults in convexity or angulation to the left, the degree of
angulation varying according to the patient. By reviewing
the cholangiographic findings of 270 patients, Liu et al. (9)
measured the degree of angulation, the mean value of
which was 140 150. A tumor such as pancreatic cancer
around the duct sometimes aggravates the degree of angu-
lation (9). 
We often encountered cases showing aggravation by the
distal portion of the stent itself of preexisting angulation of
the EHD after stent placement. Sometimes the angulation,
which hindered effective bile flow, progressed on follow-
up due to the longitudinal stretching force (straightening)
of the metallic stent. In such cases another stent was re-
quired for distal angulation, and the function of ampulla of
Vater had to be sacrificed. 
Lameris et al. (4) reported an interesting case of stent
malfunction caused by exaggerated angulation at the proxi-
mal portion of a stent placed for the palliation of distal EHD
stricture. Straightening of the short stent caused acute angu-
lation ‘above’ the stricture. They pointed out certain disad-
vantages of angulation, such as ineffective drainage and in-
creased likelihood of damage to the bile duct epithelium by
sharp wires (4). Stoker and Lameris (10) encountered two
cases of proximal occlusion caused by straightening of the
stent, a phenomenon also observed by Huibergtse (19), us-
ing a Wallstent. They found that the straightened proximal
tip of a stent embedded in the bile duct wall hindered bile
flow, and this facilitated sludge formation. Stoker and
Lameris (10) suggested that in selected cases, a longer stent
or one with a smaller diameter and less expansive force
should be used. Self-expanding metallic stents will eventual-
ly straighten with time, to a certain extent, although the
longitudinal flexibility of a Wallstent is slightly less than
that of the stents we used (20, 21). This implies that if the
proximal or distal ends of the stent are located near the
bending portion of the bile duct when the rule of simple
over-stenting is applied, it is important to overcome the
problem of angulation. It is therefore wise to choose a stent
which is long enough to successfully traverse the bending
portion of the bile duct (4). When this is  located below the
stricture, the transpapillary method should be applied.
We recommend the transpapillary method for the pallia-
tion of type-A or C lesions in which the stricture is close to
the ampulla of Vater or the bile duct is angulated below
the stricture. For type-B or D lesions in which the stricture
is far from the ampulla of Vater or bile duct angulation oc-
curs apart from the stricture so that the stent can be placed
without aggravation of preexisting angulation, a conven-
tional suprapapillary method can easily be applied. If the
suggested indication is applied, the number of cases
amenable to the transpapillary method increases very con-
siderably. Rieber et al. (22) placed transpapillary stents in
22 of their 65 patients, even though the method was ap-
plied in restricted cases. When they were sure that the
papilla was not involved, suprapapillary placement was at-
tempted. In our series, where our indication was applied,
the transpapillary method was indicated in 38 of 59 pa-
tients (64%). 
Although some authors have suggested that duodenal ul-
ceration and subsequent bleeding or perforation of the
duodenum, as well as both reflux of duodenal content into
the bile duct (once believed to be a cause of early stent
dysfunction) and pancreatitis are complications of the
transpapillary method of stent placement, the cases they
encountered were limited (12 15). In spite of concerns
over these complications, most reports describing the long-
term results of metallic stent insertion have demonstrated
that their incidence is very low (2, 12). Interestingly, most
reports of bleeding involved cases in which the prototype
Wallstent was used (15). The sharp struts of both ends of
the stent might cause mucosal injury. Nowadays,
Wallstents and other commercially available stents have
relatively smooth edges and this problem does not, there-
fore, exist. Gordon et al. (2) reported that they did not en-
counter such complications, though Stoker and Lameris
(10) described two cases of duodenal pressure ulcer among
135 patients who had undergone transpapillary Wallstent
placement. Though we were unable to analyze the compli-
cations arising from the methods employed in this retro-
spective study, the transpapillary method gave rise to no
serious complication. There were, however, relatively fre-
quent incidences of epigastric discomfort after placement,
and these might be caused by inadvertent dilatation of the
ampulla of Vater by the stent. Within two or three days,
however, they subsided spontaneously. 
Other than a brief comment by Rieber et al. (22), no ra-
diologic report has compared the efficiency with which the
suprapapillary and transpapillary methods of stent place-
ment palliate malignant biliary obstruction. Rieber et al.
(22) found that the occlusion rate of a stent was not influ-
enced by its position. A further report on the same subject
(23) dealt with endoscopically-placed plastic stents, con-
cluding that there was no significant difference in patency
and complication rates. We observed similar results: there
were no significant differences in early recurrence and
long-term patency rates between the two methods.
In conclusion, a careful review of cholangiograms with
regard to stricture location and EHD angulation, as well as
proper application of stent placement methods, are manda-
tory procedures if malignant biliary strictures are to be suc-
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associated with angulation of the bile duct below the stric-
ture, the transpapillary method of stent placement should
be considered.
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